Purpose of the KOMPLETE Study
The purpose of the KOMPLETE Study is to understand the effects of an investigational oral medication called KVD824 in adults 18 years of age and older with HAE type I or type II. Investigational means that KVD824 has not yet been approved to treat HAE and can only be used in a research study. Doctors are studying 3 different doses to see which one may be best as a safe prophylaxis treatment for HAE attacks (meaning whether or not it works to prevent attacks).
